
Contineum Therapeutics Grants Equity Awards Under Nasdaq Rule 5635(c)(4)
Contineum Therapeutics, Inc. Reports Inducement Equity Grants Under Nasdaq Rule 5635(c)(4) Contineum Therapeutics a clinical-stage biopharmaceutical company focused on developing differentiated therapies for neuroscience, inflammation, and immunology (NI&I) indications, has…












